Irritable Bowel Syndrome Treatment Market By Drug Class (Antidiarrheals, Laxatives, Secretagogues/Prosecretory agents, Antispasmodics, Antibiotics, Retainagogues, Antidepressants/Neuromodulators, Other), By Disease Type (Irritable Bowel Syndrome with Constipation (Irritable Bowel Syndrome-C), Irritable Bowel Syndrome with Diarrhea (Irritable Bowel Syndrome-D), Mixed Irritable Bowel Syndrome (Irritable Bowel Syndrome-M)), By Application (Pain Management, Diarrhea Management, Constipation Management), By End-user (Hospitals, Specialty Clinics, Research and Academic Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Drug Class

• Antidiarrheals
• Laxatives
• Secretagogues/Prosecretory agents
• Antispasmodics
• Antibiotics
• Retainagogues
• Antidepressants/Neuromodulators
• Other

By Disease Type

• IBS with Constipation (IBS-C)
• IBS with Diarrhea (IBS-D)
• Mixed IBS (IBS-M)

By Application

• Pain Management
• Diarrhea Management
• Constipation Management

End-user

• Hospitals
• Specialty Clinics
• Research and Academic Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• AbbVie
• Allergan
• AstraZeneca
• Pfizer
• Bayer
• Synergy Pharmaceuticals
• Ironwood Pharmaceuticals
• Tillotts Pharma
• Zynerba Pharmaceuticals
• Novartis
• Gilead Sciences
• Takeda Pharmaceutical Company
• Sandoz
• Johnson & Johnson
• Replimune
• Bristol Myers Squibb
• Vanda Pharmaceuticals
• Meda Pharmaceuticals